WhizAI Pharmaceutical Marketing Analytics Features
- Real-Time Data:
With WhizAI, there’s no need to wait for data insights. Marketing teams can access information on-demand rather than wait for a data or IT team to work analysis into its schedule.
- Industry-Specific Training:
Generic AI platforms may claim to work for life sciences use cases. However, they take months of training before they can deliver relevant, accurate insight to life sciences teams. WhizAI is pre-trained for life sciences and deploys in just a few weeks.
- Natural Language Processing (NLP):
WhizAI leverages NLP, which allows the platform to understand a pharma marketing team’s question using terms, phrasing, and acronyms they’d normally use – and answers using terminology and metrics that users are accustomed to.
- Contextual Insights:
Pharmaceutical marketing analytics from WhizAI are specific to the product, market, and region the team asks about, unlike dashboards that are created to provide information to a broad range of users.
How WhizAI Works
WhizAI combines data from primary and secondary sources and quickly analyzes petabytes of data within a sub-second – and it automatically scales as data volumes grow. This gives marketers the ability to use both industry data and internal data from marketing campaign performance to optimize campaigns with minimal intervention from the data team.
WhizAI’s hybrid AI engine combines pre-trained and configurable models to provide industry-leading domain expertise. Furthermore, every time a user asks a question, asks follow-up queries, and interacts with the platform, WhizAI learns, continually refining the user’s intent and context.
Although WhizAI can be used as an advanced pharmaceutical marketing analytics solution, it doesn’t require advanced expertise in data analytics. It’s designed to make data insights accessible and consumable, taking only a few minutes of training, regardless of data science or IT expertise.
Additionally, life sciences marketing teams can use WhizAI as a standalone solution or as a complement to BI dashboards to paint a total picture of opportunities, marketing tactics and campaigns that have historically been most effective with the target audience and how well current campaigns are performing.
The Benefits of Instant Access to Pharmaceutical Marketing Analytics
Data-driven decision making:
WhizAI is as intuitive as a social media app, making it easy for marketers to build data-driven decision making into their daily workflows – and see greater productivity and improved outcomes. It’s common for a company deploying WhizAI to see 100% adoption.
Less dependence on the data team:
WhizAI is intuitive. Users can create their own dashboards and choose the visualizations they prefer in a no-code environment. Life sciences companies using WhizAI decrease dependence on their IT teams by as much as 60%.
More effective marketing:
Pharmaceutical marketing analytics confirms what’s working – and what isn’t. Insights from WhizAI allow marketers to develop a product value story from development to clinical trials and commercialization.
Insights for marketers on the move:
Marketers can embed WhizAI in the applications they use, allowing them to access data insights with just a click. Additionally, users can access pharmaceutical marketing analytics from a PC, laptop, tablet, or smartphone.
When marketing campaigns are based on data and teams have real-time access to their effectiveness, life science companies have greater visibility and more control over the success of a campaign. Marketers can elevate brands, help increase market penetration, and improve the bottom line.
To learn more about connecting your team with instant access to pharmaceutical marketing analytics, join a weekly demo to see WhizAI in action or contact us.
Accelerating Decision-Making with AI-Powered Analytics in Life Sciences to Drive Commercial Success
Gartner Reports Augmented Consumerization Will Drive Analytics Adoption by 2025
Life science companies considering which augmented analytics platform is the optimal choice for their organization will find a list of Augmented Analytics Tool Vendors and Products at the end of the Gartner Market Guide for Augmented Analytics.
Gartner Reports AI in Clinical Development is Only 2-5 Years from Mainstream Adoption
WhizAI is recognized as a Sample Vendor for AI in clinical development, a high-benefit technology already seeing market penetration.
Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations
The Gartner® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.
Market Access Team Stays Ahead of the Curve with WhizAI-Powered Insight-Driven Decisions
After investing in self-service analytics platforms, this global pharmaceutical company discovered the ease, usability — and ROI — of WhizAI.
Global Pharma Patient Services Team Manages 20,000+ Patients with Insights from WhizAI
This patient services team now has visibility into the entire patient journey, identify risks, and increase productivity by a factor of five.